UnitedHealth Group Inc EV/EBITDA
Data as of September 29, 2026
EV/EBITDA
14.78
Enterprise Value
$378.70B
EBITDA (TTM)
$25.62B
Sector
Health Care
How It's Calculated
14.78 = $378.70B ÷ $25.62B
What This Means
UnitedHealth Group Inc's EV/EBITDA of 14.8 is in a moderate range for Health Care.
About UnitedHealth Group Inc
UnitedHealth Group Inc (UNH) operates in the Health Care sector, specifically in Health Care. With a market capitalization of about $339.08B, it ranks as a mega-cap stock — one of the largest publicly traded companies.
Shares recently traded near $377.83, within a 52-week range of $255.97 to $461.62 (-18.2% from the high, +47.6% from the low). Beta of 0.54 indicates relatively lower volatility versus the market.
Trailing profit margin is about 3.1%, signaling modest profitability that investors should weigh against growth plans.
Understanding This Metric
EV/EBITDA is widely used when comparing companies with different debt loads because enterprise value includes net debt while EBITDA approximates operating cash earnings power. For UnitedHealth Group Inc, the ratio should be read with growth, capex needs, and cycle position in Health Care. Pair EV/EBITDA with free cash flow yield and net debt metrics before drawing conclusions — especially when EBITDA is depressed or boosted by one-time items.
Using This Number in Practice
Near 14.78x EV/EBITDA, UnitedHealth Group Inc (UNH) carries a mid-range EV/EBITDA multiple that investors often stack-rank within the sector. Enterprise value of about $378.70B and EBITDA near $25.62B form the ratio — adjust for one-time items before treating the headline multiple as comparable.
Credit and LBO workflows often sort names on EV/EBITDA before drilling into free cash flow and maintenance capex. Pair this view with the EV/EBITDA calculator and the UNH metrics hub for related valuation pages.
Sector Comparison
Among Health Care names on our S&P 100 coverage, UnitedHealth Group Inc's EV/EBITDA of 14.78 can be compared with peers such as ABT (21.94), CVS (18.87), MDT (16.45). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Health Care stocks.
Key Takeaways
- UNH is grouped in the Health Care sector for peer comparisons.
- Recent beta of 0.54 suggests lower-than-market price sensitivity.
- Trailing profit margin of 3.1% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for UNH.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other UNH Metrics
Frequently Asked Questions
What is UNH's EV/EBITDA?
EV/EBITDA compares enterprise value to operating earnings before interest, taxes, depreciation, and amortization. UnitedHealth Group Inc's ratio is about 14.78 — common for comparing leveraged companies in Health Care.
Is 14.78 high or low vs peers?
Among Health Care peers (e.g. ABT (21.94), CVS (18.87), MDT (16.45)), UNH's 14.78 should be read with growth, capex, and debt levels.
When is EV/EBITDA misleading?
EBITDA ignores capex, working capital, and stock-based comp; negative or tiny EBITDA makes the ratio meaningless. Cross-check with free cash flow and net debt.
Calculate the ev/ebitda for any stock with our free calculator.
Open EV/EBITDA Calculator →